Participants
Contact
Diario Médico devotes an article to the line of research undertaken by Ernest Giralt at IRB Barcelona, together with associate researcher Meritxell Teixidó. The journalist explains the technology behind peptide shuttles that cross biological obstacles such as the blood-brain, gastrointestinal and cell membrane barriers. The objective is to design and synthesize peptides that bind to therapeutic molecules and transport them to specific sites.
Read the feature article in Diario Médico (PDF in Spanish)
Link to Diario Médico
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
